Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

NCT00939237 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

213

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Ateronon
DRUG: Placebo

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]
[object Object]